Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Naltrexone in the treatment of opioid dependence.

× No keyword cloud information.

4 in total

1. In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opioid receptor modulator.

Authors: Samuel Obeng; Yunyun Yuan; Abdulmajeed Jali; Dana E Selley; Yan Zhang
Journal: Eur J Pharmacol Date: 2018-03-09 Impact factor: 4.432

2. Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.

Authors: Yan Zhang; Amanda Braithwaite; Yunyun Yuan; John M Streicher; Edward J Bilsky
Journal: Eur J Pharmacol Date: 2014-05-08 Impact factor: 4.432

3. Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorder.

Authors: Yi Zheng; Samuel Obeng; Bethany A Reinecke; Chongguang Chen; Palak S Phansalkar; David M Walentiny; Phillip M Gerk; Lee-Yuan Liu-Chen; Dana E Selley; Patrick M Beardsley; Yan Zhang
Journal: Eur J Pharmacol Date: 2019-11-16 Impact factor: 4.432

Review 4. Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary care.

Authors: Jinhee Lee; Thomas F Kresina; Melinda Campopiano; Robert Lubran; H Westley Clark
Journal: Biomed Res Int Date: 2015-01-05 Impact factor: 3.411

4 in total